Carroll Financial Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,410
| Closed | -$232K | – | 2026 |
|
|
2021
Q2 | $232K | Sell |
1,410
-5
| -0.4% | -$835 | 0.01% | 380 |
|
|
2021
Q1 | $216K | Sell |
1,415
-95
| -6% | -$12.9K | 0.01% | 384 |
|
|
2020
Q4 | $189K | Hold |
1,510
| – | – | 0.01% | 375 |
|
|
2020
Q3 | $153K | Hold |
1,510
| – | – | 0.01% | 388 |
|
|
2020
Q2 | $146K | Hold |
1,510
| – | – | 0.01% | 385 |
|
|
2020
Q1 | $125K | Buy |
1,510
+100
| +7% | +$9.75K | 0.01% | 384 |
|
|
2019
Q4 | $156K | Hold |
1,410
| – | – | 0.01% | 417 |
|
|
2019
Q3 | $139K | Hold |
1,410
| – | – | 0.01% | 437 |
|
|
2019
Q2 | $139K | Sell |
1,410
-107
| -7% | -$10.2K | 0.01% | 431 |
|
|
2019
Q1 | $167K | Buy |
1,517
+107
| +8% | +$11.2K | 0.02% | 350 |
|
|
2018
Q4 | $128K | Hold |
1,410
| – | – | 0.01% | 335 |
|
|
2018
Q3 | $155K | Hold |
1,410
| – | – | 0.02% | 319 |
|
|
2018
Q2 | $131K | Hold |
1,410
| – | – | 0.01% | 332 |
|
|
2018
Q1 | $116K | Hold |
1,410
| – | – | 0.01% | 352 |
|
|
2017
Q4 | $128K | Hold |
1,410
| – | – | 0.01% | 334 |
|
|
2017
Q3 | $112K | Buy |
1,410
+790
| +127% | +$59.7K | 0.01% | 353 |
|
|
2017
Q2 | $46K | Hold |
620
| – | – | 0.01% | 515 |
|
|
2017
Q1 | $40K | Buy |
+620
| New | +$36.5K | 0.01% | 521 |
|
Other funds holding PRAH
Carroll Financial Associates's PRAH Position: Q3 2021 in Review
Carroll Financial Associates sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,410 shares — an estimated $232K sold.
Carroll Financial Associates first reported a position in PRAH in Q1 2017 and held it in 18 quarters. The position peaked at $232K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Carroll Financial Associates reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Carroll Financial Associates sold 1,410 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $232K.
- Carroll Financial Associates first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 18 quarters.
- Carroll Financial Associates's PRA Health Sciences, Inc. position peaked at $232K in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Carroll Financial Associates's 13F filing for Q3 2021, filed 7 Oct 2021.